Empower Clinics Announces US Distribution Agreement with Integrated Cannabis Company

SEATTLE–(BUSINESS WIRE)–Empower Clinics Inc. (OTC: EPWCF; CSE: EPW; FRA: 8EC), a leading owner and operator of medical cannabis and wellness clinics in the US, today announced a national distribution agreement with Integrated Cannabis Company, Inc. (CSE: ICAN) (OTCQB: ICNAF).

“This agreement provides an additional revenue stream for Empower while enabling us to offer more world-class treatment options tied to some of the most common conditions our patients face”

Under the agreement, Integrated Cannabis will distribute CBD-infused X-SPRAYS™ products including: CBD, Sleep, Recover, Libido and Energy throughout the Empower network of clinics in Washington, Oregon, and Illinois as well as on Empower’s Website in the coming weeks. Both companies have engaged with their marketing and distribution teams to streamline the logistics of rolling out new products in the Empower clinics.

X-SPRAYS products are backed by technology that enables metered dosing, based on each patient’s specific needs. The CBD products are non-psychotropic: they do not directly affect mood, perception, or consciousness.

“This agreement provides an additional revenue stream for Empower while enabling us to offer more world-class treatment options tied to some of the most common conditions our patients face,” said Craig Snyder, Empower CEO. “X-SPRAYS’ combination of quality products and technology perfectly fits our line of treatments, and we look forward to working with Integrated Cannabis Company to expand the scope and variety of options available to our patients.”

“Empower Clinics is executing an ambitious national expansion strategy and we’re excited to become a key component of their product offerings,” said John Knapp, CEO of Integrated Cannabis. “Our two organizations are strongly aligned in treating a growing population of patients who are dealing with opioid addiction, pain, anxiety, sleep issues, as well as those seeking overall well-being.”

ABOUT EMPOWER

Empower is a leading owner and operator of medical cannabis and wellness clinics, as well as a developer of medical products in the US, focused on enabling individuals to improve and protect their health. The company provides treatment solutions through its physician-staffed clinics that are focused on education, data, and efficacy. Empower is a recognized leader and the first choice for patients seeking quality experience and improved health.

For further information about Empower please see the Company’s website at www.empowerclinics.com.

Certain statements included in this press release constitute forward-looking information or statements (collectively, “forward-looking statements”), including those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management. The forward-looking statements are not historical facts but reflect current expectations regarding future results or events and are therefore based on current expectations and various estimates, factors and assumptions and involve known and unknown risks, uncertainties and other factors.

Neither the Canadian Securities Exchange nor the Frankfurt Stock Exchange accepts responsibility for the adequacy or accuracy of this release.

Contacts

Investors:
Boom Capital Markets
Steve Low, 647-620-5101
steve@boomcapitalmarkets.com
or
Press:
Mark Peterson, 206-390-0204
mark@pointerpr.com

By |2018-10-11T21:59:15+00:00October 4th, 2018|CBD, Finance, Marketing, News, Press|
Empower Clinics Inc.
Exchange: CSE
Symbol: EPW
Last Price: 0.245
Change: -0.035
Volume: 169021
Last Updated: 10/22/2018 03:18:17 PM EST
GDPR Compliance Notice: This site uses cookies and third party tracking scripts to help us improve your website and shopping experience. By continuing to browse our website you are agreeing to our cookie and privacy policies. View Our Privacy Policy Continue